EKF Diagnostics Holdings (EKF)

Sector:

Financials

Index:

FTSE AIM All-Share

25.80p
   
  • Change Today:
      0.45p
  • 52 Week High: 32.70
  • 52 Week Low: 18.75
  • Currency: UK Pounds
  • Shares Issued: 454.93m
  • Volume: 165,393
  • Market Cap: £117.37m
  • Beta: 0.06

EKF ends year ahead of already-upgraded expectations

By Josh White

Date: Tuesday 25 Jan 2022

LONDON (ShareCast) - (Sharecast News) - Point-of-care, central laboratory device and chemistry reagent company EKF Diagnostics said on Tuesday that continued strong trading would result in its performance for 2021, including adjusted EBITDA, ahead of already-upgraded market expectations.
The AIM-traded firm said trading in its core business in the final quarter was "robust", with ongoing demand for sample collection kits and testing strong through to year-end on 31 December.

It announced that core business revenues grew over 13% year-on-year, while group cash, net of borrowings, at 31 December was £19.6m, compared to £21.4m a year earlier.

The board said that reflected further strong operational cash generation offset by substantial investment in the business, some working capital expansion to support anticipated growth, and the payment of the 1.1p per ordinary share cash dividend in December in line with the company's progressive dividend policy.

"During the year, and as part of the group's strategy, significant investment was made to expand fermentation capabilities and contract manufacturing to drive further organic growth," the directors said in their statement.

"Further investment in enzyme fermentation is scheduled for 2022 in this key strategic growth area.

"Growth and investment in the core business is complemented by a strategy to exploit expanded capabilities to meet the demand for contract manufacturing services."

EKF said Advanced Diagnostic Laboratory, the CLIA-certified lab testing business acquired in October, was integrating well and had started diversifying into non-Covid-19 testing, as evidenced by its recent partnership for the provision of a non-invasive prenatal testing service.

EKF said it would give further guidance on current trading and its outlook for 2022 and beyond when it reports its audited full year results.

At 1011 GMT, shares in EKF Diagnostics Holdings were up 2.39% at 68.6p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

EKF Market Data

Currency UK Pounds
Share Price 25.80p
Change Today 0.45p
% Change 1.78 %
52 Week High 32.70
52 Week Low 18.75
Volume 165,393
Shares Issued 454.93m
Market Cap £117.37m
Beta 0.06

EKF Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
87.54% below the market average87.54% below the market average87.54% below the market average87.54% below the market average87.54% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Price Trend
30.03% below the market average30.03% below the market average30.03% below the market average30.03% below the market average30.03% below the market average
33.96% below the sector average33.96% below the sector average33.96% below the sector average33.96% below the sector average33.96% below the sector average
Income Not Available
Growth
58.00% above the market average58.00% above the market average58.00% above the market average58.00% above the market average58.00% above the market average
52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average52.17% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EKF Dividends

  Latest Previous
  Final Final
Ex-Div 02-Nov-23 03-Nov-22
Paid 01-Dec-23 01-Dec-22
Amount 1.20p 1.20p

Trades for 28-May-2025

Time Volume / Share Price
16:35 352 @ 25.80p
16:35 101 @ 25.80p
16:35 214 @ 25.80p
16:35 1 @ 25.80p
16:35 21 @ 25.80p

EKF Key Personnel

CFO Stephen (Steve) Young
CEO Gavin T Jones

Top of Page